Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study
Open Access
- 1 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 14 (2), R65
- https://doi.org/10.1186/cc8964
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoNew England Journal of Medicine, 2009
- Dating the emergence of pandemic influenza virusesProceedings of the National Academy of Sciences, 2009
- Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutantPublished by American Society of Hematology ,2009
- Distinct Functions of Activated Protein C Differentially Attenuate Acute Kidney InjuryJournal of the American Society of Nephrology, 2009
- InfluenzaCritical Care Medicine, 2008
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CThe Journal of Experimental Medicine, 2007
- Protein C in pneumoniaThorax, 2005
- Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationNew England Journal of Medicine, 2004
- Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumoniaBlood, 2003
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.JCI Insight, 1987